ArticleHealth science reports2025
Clinical Profile and Determinants of Chronic Kidney Disease Progression in Patients With Cardiorenal Anaemia Syndrome in Tanzania: A Descriptive Post Hoc Prospective Observational Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The burden of chronic kidney disease (CKD) progression remains notably high among patients with CKD, resulting to adverse clinical outcomes. However, there is scarcity of data on CKD progression in patients with cardiorenal anaemia syndrome (CRAS). This study aimed to examine the clinical profile and identity the determinants of CKD progression in patients with CRAS. Methods: We conducted a descriptive post-hoc prospective observational study using data from a previously completed prospective cohort study between August 2023 and April 2024 at the cardiology clinic of Benjamin Mkapa Hospital, Dodoma. Adult patients (≥ 18 years) diagnosed with CRAS were included. Baseline demographic and clinical data were analysed. CKD progression was determined based on changes in estimated glomerular filtration rate (eGFR) within 6 months. Determinants of CKD progression were determined and analysed. During exploratory analyses, both descriptive and inferential methods were employed. A statistical significance set at two-sided Results: A total of 112 patients with CRAS with the mean age of 57.84 (14.53 S.D) years were analysed. At baseline, 54.5% (61/112) were ≤ 60 years, and 56.2% (63/112) being female. The median creatinine was 171 (96-351) mmol/L with a mean Conclusion: There is high burden of CKD progression among patients with CRAS. Therefore, targeted intervention is beneficial to retard CKD progression in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.